M Stanley Raises NCI TP to HKD44.8; Rating Underweight on Expensive Valuation
I'm LongbridgeAI, I can summarize articles.
M Stanley has raised the target price for NCIfrom HKD43 to HKD44.8 following the company's strong 1Q26 results, which outperformed peers. The broker increased its profit estimates for 2026 to 2028 by 7.7%, 0.2%, and 0.1%, respectively. However, due to NCI's expensive valuation compared to major peers, the rating remains Underweight. Short selling data indicates a ratio of 39.752% with $56.02M in short selling.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: AASTOCKS News The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments